echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > State directive to fix all hospital rebates covert visit group departure.

    State directive to fix all hospital rebates covert visit group departure.

    • Last Update: 2020-08-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the National Health And Health Commission issued the "2020 medical industry style construction work special action plan", the focus of this program is to standardize the behavior of medical institutions and their practitioners, issued to the provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps Health Committee, began to organize the implementation.
    this special rectification is implemented in three stages: the first stage is the education and self-examination phase (July 2020).
    at all levels of health and health administrative departments and medical institutions to organize a working meeting, all types of medical institutions at all levels and all medical personnel to strictly implement the "nine not allowed" requirements, self-examination and self-correction.
    into August, it officially entered the stage of centralized publicity and rectification.
    local health and health administrative departments are responsible for investigating and prosecuting the receipt of "red envelopes" and kickbacks by medical institutions and medical personnel at the same level, collecting and sorting out clues reported by the masses and investigating or transferring them to relevant departments for investigation and prosecution in accordance with their duties.
    (screenshot source: National Health Care Commission) at the same time, the relevant departments will be jointly related to the daily medical behavior and internal management of the inspection, and the problems found to focus on the rectification.
    all regions continue to carry out special inspections and covert visits, strengthen the main responsibility of medical institutions and practitioners, expose cases of violations of discipline, establish a reporting information system, large medical expenses check mechanism and joint prevention and control mechanism.
    the scope of centralized remediation should achieve full coverage of hospitals (including Chinese hospitals and maternal and child health care hospitals) in the jurisdiction, and more than 50% coverage of other types of medical institutions (community health service centers (stations), outpatient clinics and clinics).
    interview specific people for evidence, what is a covert visit? How to covertly visit? What will be involved? According to the experience of many provinces in the field of medicine covert visits, you can learn that covert visits that do not send notice in advance, do not say hello, do not listen to reports, do not accompany the reception, go straight to the scene way.
    inspection enterprises, random spot checks of medical service institutions, grass-roots regulatory agencies, to find drugs, medical devices, cosmetics supervision in the existence of outstanding problems, weak links.
    secret visit inspection to take field investigation, covert visit visit, specific person interview, sampling testing and other means, through audio and video recording, telephone consultation, simulation and other means.
    Covert content such as research GSP ticket peers, consistent, drug business has no hanging, pass, the drug purchase inspection clearance situation, whether in accordance with the provisions equipped with practicing pharmacists, practicing pharmacists are on duty, whether drugs are purchased from legitimate channels and so on.
    most importantly, the covert investigation will focus on the objects of high attention, many complaints, daily management confusion, high risk level and high social impact, and increase the intensity of random spot checks.
    Why the use of covert way, the recent release of the official website of the Central Commission for Discipline Inspection "on the management of bribery in the field of medicine" article caused a lot of concern, the content refers directly to the pharmaceutical industry to withdraw deductions, commissions, thank you fees and other acts, and pointed out that the pharmaceutical sector bribery and bribery problems are repeatedly prohibited, the urgent need to cure the disease.
    article points out that from the cases investigated in recent years, the means of bribery in the field of medicine show the characteristics of fancy renovation, frequent, huge amount of money and so on.
    pharmaceutical representatives admitted that with the drug price of about 45% rebates, soliciting second-level agents in the hospital to open sales channels.
    with the strengthening of supervision, bribery methods are more covert, such as for doctors to ask for babysitters, help their children go to school, or bribery as consulting fees, promotional fees and so on.
    face recognition check medicine representative notice clearly stated that the pharmaceutical representative will be strictly checked to promote drugs, equipment.
    , the distribution personnel of pharmaceutical products production and operation enterprises will be seriously investigated for illegal marketing practices in medical institutions.
    shall focus on examining the illegal sale of medicines and medical devices to medical personnel by pharmaceutical products production, business enterprises or distribution personnel in areas such as outpatient clinics, inpatient departments and pharmacies of medical institutions, and conduct commercial negotiations.
    it is understood that big data and artificial intelligence technology will be used in this rectification.
    medical institutions shall make full use of artificial intelligence or information technology to provide early warning, monitoring and timely treatment of the marketing practices of distribution personnel of pharmaceutical products production and operation enterprises entering the medical institutions to engage with medical personnel.
    scope and theme, the document shows that medical institutions and their practitioners will strengthen the supervision of practice behavior, advocating integrity from medicine.
    Through letters and visits, reports, departmental collaboration and other means of comprehensive and in-depth investigation of clues, focusing on the examination of all levels of medical institutions practitioners (including doctors, nurses, medical technicians, administrative personnel) to use the convenience of their position, in medical activities (including the introduction of admission, examination, treatment, surgery and other links) to obtain or receive patients and their families in various names to give "red envelope" gifts or other improper benefits of illegal acts.
    Strictly investigate the use of any means and means by medical personnel for commercial purposes to statistics physicians and clinical departments on the use of drugs, medical supplies, to facilitate the statistics of pharmaceutical marketing personnel;
    the unreasonable diagnosis and treatment behavior into the performance appraisal system of medical personnel for supervision and evaluation.
    shall, in accordance with the law, be included in the management of the credit system for bad practice in medical institutions in accordance with the law for serious violations such as violations of medical treatment routines, induced medical treatment and excessive medical treatment, and shall be published to the public.
    Central Committee stressed that adhere to the bribery and bribery investigation together, huge bribes, many bribes serious treatment.
    in various parts of the country have also launched corrective action.
    Anhui Province to carry out three-level joint inspection of the health system, promoting the investigation and prosecution of a number of problem clues, illegal bidding procurement, receipt of kickbacks and other aspects of the negative list.
    Jiangxi Province in the "province's pharmaceutical circulation in the field of commercial bribery special corrective action work program" clearly, scientific research fees, party fees, sponsorship fees, new drug promotion fees are defined as commercial bribery.
    Tianjin Issued the Measures for the Administration of Reception of Representatives of Pharmaceutical Operating Enterprises in Tianjin Hospital, strengthened the management of pharmaceutical representatives, and insisted on cracking down on the corrupt hospital leaders, medical personnel and other acts by any means, and squeezing the "encumeration" space.
    and so on according to Theo Blue device observation, inspections are already under way everywhere, from the industry's point of view, strict regulation is not the accelerator to promote the progress of the industry.
    every wave of industry consolidation is a process of false existence, is the best protection of compliance, legitimate enterprises.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.